CRANEWARE PLC

Share Issue/Capital Change • Sep 2, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9030K

Craneware plc

02 September 2019

Craneware plc

("Craneware", "the Group" or the "Company")

Blocklisting Application

Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, announces that an application has been made to the London Stock Exchange for 372,219 ordinary shares of one pence each ("Ordinary Shares") to be admitted to trading on AIM (the "Admission"). All these Ordinary Shares are being reserved under an extension to an existing block listing and will be issued as required in order to satisfy the exercise of share options pursuant to the 2007 Share Option Plan.

It is expected that Admission of these Ordinary Shares will become effective on 6 September 2019. When issued, the Ordinary Shares will be credited as fully paid and will rank pari passu in all respects with the existing Ordinary Shares.

For further information, please contact:

Craneware plc	Peel Hunt (NOMAD)	Alma (Financial PR)
+44 (0)131 550 3100	+44 (0)20 7418 8900	+44 (0)203 405 0212
Keith Neilson, CEO	Dan Webster	Caroline Forde
Craig Preston, CFO	George Sellar	Hilary Buchanan
	Guy Pengelley	Helena Bogle

About Craneware

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

Craneware is the leader in automated Value Cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 350 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

ALSUGUUPBUPBGUP